Department of Defense (DoD): NAICS 325413 — In-Vitro Diagnostic Substance Manufacturing

5open solicitations
$32.1Mobligated in FY2026
34contracts ending within 18 months

Open solicitations

Open any solicitation for a free AI read of its package — deal-breakers and risks, each quoted from the page it came from. With a free account, FedSift also builds its compliance matrix.

How DoD NAICS 325413 spends

FY2021$1.3B
FY2022$4.7B
FY2023$556.3M
FY2024$41.4M
FY2025$34.8M
FY2026$32.1M
FY2027*$1.4M

Contract obligations by federal fiscal year (October–September), from USASpending.gov award data. IDIQ ceilings are excluded. * The current year is partial, and USASpending lags 4–8 weeks.

DoD NAICS 325413 contracts expiring in the next 18 months

34 contracts worth $18.6M.

IncumbentBuyerWhatValueEndsEst. solicitationRecord
BIOMERIEUX INCAir Force325413 In-Vitro Diagnostic Substance Manufacturing$79K24 December 2026Now / imminentDetails
QUIDELORTHO SALES COMPANY, LLCAir Force325413 In-Vitro Diagnostic Substance Manufacturing$124K31 December 2026Now / imminentDetails
ONE LAMBDA, INC.Defense Health Agency325413 In-Vitro Diagnostic Substance Manufacturing$847K09 February 2027Now / imminentDetails
BIOCARE MEDICAL LLCDefense Health Agency325413 In-Vitro Diagnostic Substance Manufacturing$225K24 March 2027Now / imminentDetails
ROCHE DIAGNOSTICS CORPORATIONNavy325413 In-Vitro Diagnostic Substance Manufacturing$32K27 March 2027Now / imminentDetails
SIEMENS HEALTHCARE DIAGNOSTICS INC.Army325413 In-Vitro Diagnostic Substance Manufacturing$65K31 March 2027Now / imminentDetails
MAXIM BIOMEDICAL, INCNavy325413 In-Vitro Diagnostic Substance Manufacturing$155K18 May 2027Now / imminentDetails
NOVA BIOMEDICAL CORPArmy325413 In-Vitro Diagnostic Substance Manufacturing$44K31 July 2027~Q1 2027Details
ROCHE DIAGNOSTICS CORPORATIONArmy325413 In-Vitro Diagnostic Substance Manufacturing$3.0M30 September 2027~Q2 2027Details
HOLOGIC SALES AND SERVICE, LLCArmy325413 In-Vitro Diagnostic Substance Manufacturing$1.8M30 September 2027~Q2 2027Details
BECKMAN COULTER, INCArmy325413 In-Vitro Diagnostic Substance Manufacturing$1.7M (2 orders)30 September 2027~Q2 2027Details
WERFEN USA LLCArmy325413 In-Vitro Diagnostic Substance Manufacturing$1.7M (3 orders)30 September 2027~Q2 2027Details
FISHER SCIENTIFIC COMPANY L.L.C.Army325413 In-Vitro Diagnostic Substance Manufacturing$1.6M30 September 2027~Q2 2027Details
ABBOTT LABORATORIES INC.Army325413 In-Vitro Diagnostic Substance Manufacturing$1.4M30 September 2027~Q2 2027Details
SL MEDITECH CO.Army325413 In-Vitro Diagnostic Substance Manufacturing$1.2M30 September 2027~Q2 2027Details

Contracts and task orders from USASpending.gov (FPDS) whose period of performance ends within 18 months, valued at $25K or more, excluding IDIQ ceilings and government-owned, contractor-operated facility contracts. Co-terminous orders from the same vendor, agency, NAICS and PSC ending in the same month are grouped. The solicitation date is an estimate (about six months before the contract ends): FedSift does not know whether a follow-on has been posted, so check SAM.gov.

NAICS 325413 across every agency → · Everything DoD has open →

FedSift turns SAM.gov and USASpending data into federal BD intelligence — smart matches, recompete radar, cited AI solicitation analysis and compliance matrices.

Source data: SAM.gov (solicitations) and USASpending.gov (awards), refreshed nightly. FedSift is not affiliated with the U.S. Government.

Pricing · Privacy · Terms · support@fedsift.app